Merck Stock Falls After Earnings. Keytruda Sales Top $8 Billion for First Time.

Published 1 week ago Positive
Merck Stock Falls After Earnings. Keytruda Sales Top $8 Billion for First Time.
Auto
Merck boosts its full-year outlook as third-quarter earnings top estimates following strong demand for its blockbuster cancer drug.

Continue Reading

View Comments

More News

New York man wants to borrow from 401(k) to pay $33K debt. Dave Ramsey is against it, but here's when it makes sense

56 minutes ago Positive

Trump revives proposal for $2,000 tariff dividend to most Americans

1 hour ago Positive

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

1 hour ago Positive

Can Apple Shares Surge Past $300 This Year?

1 hour ago Positive

Market volatility poised to rise as investors brace for uncertainty

1 hour ago Positive